1. Home
  2. OMCL vs GSBD Comparison

OMCL vs GSBD Comparison

Compare OMCL & GSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMCL
  • GSBD
  • Stock Information
  • Founded
  • OMCL 1992
  • GSBD 2012
  • Country
  • OMCL United States
  • GSBD United States
  • Employees
  • OMCL N/A
  • GSBD N/A
  • Industry
  • OMCL Computer Manufacturing
  • GSBD Finance: Consumer Services
  • Sector
  • OMCL Technology
  • GSBD Finance
  • Exchange
  • OMCL Nasdaq
  • GSBD Nasdaq
  • Market Cap
  • OMCL 1.5B
  • GSBD 1.3B
  • IPO Year
  • OMCL 2001
  • GSBD N/A
  • Fundamental
  • Price
  • OMCL $31.18
  • GSBD $11.26
  • Analyst Decision
  • OMCL Buy
  • GSBD Sell
  • Analyst Count
  • OMCL 7
  • GSBD 1
  • Target Price
  • OMCL $46.71
  • GSBD $10.00
  • AVG Volume (30 Days)
  • OMCL 470.2K
  • GSBD 523.8K
  • Earning Date
  • OMCL 10-29-2025
  • GSBD 11-06-2025
  • Dividend Yield
  • OMCL N/A
  • GSBD 11.36%
  • EPS Growth
  • OMCL N/A
  • GSBD 52.30
  • EPS
  • OMCL 0.49
  • GSBD 1.24
  • Revenue
  • OMCL $1,149,529,000.00
  • GSBD $402,124,000.00
  • Revenue This Year
  • OMCL $5.37
  • GSBD N/A
  • Revenue Next Year
  • OMCL $3.67
  • GSBD N/A
  • P/E Ratio
  • OMCL $63.63
  • GSBD $9.07
  • Revenue Growth
  • OMCL 6.39
  • GSBD N/A
  • 52 Week Low
  • OMCL $22.66
  • GSBD $9.51
  • 52 Week High
  • OMCL $55.75
  • GSBD $14.54
  • Technical
  • Relative Strength Index (RSI)
  • OMCL 45.32
  • GSBD 45.61
  • Support Level
  • OMCL $31.73
  • GSBD $11.13
  • Resistance Level
  • OMCL $33.32
  • GSBD $11.45
  • Average True Range (ATR)
  • OMCL 0.97
  • GSBD 0.15
  • MACD
  • OMCL -0.23
  • GSBD -0.01
  • Stochastic Oscillator
  • OMCL 0.44
  • GSBD 31.25

About OMCL Omnicell Inc. ($0.001 par value)

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

About GSBD Goldman Sachs BDC Inc.

Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests primarily in U.S. middle-market companies such as banks and the public debt markets. The company focuses on the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.

Share on Social Networks: